Penn is mightily pleased with safety record
Banishing kettles, 'Gemba walks' and encouraging employees to report near misses have helped Penn Pharma to remain accident free at its high potency compound manufacturing facility in Wales.
Archives for February 10, 2015
Juno Therapeutics adds new biomanufacturing facility in Washington, will continue using CMOs
Cell-based cancer immunotherapy company Juno Therapeutics has entered into a lease agreement for a manufacturing facility in Bothell, Washington to produce its developing cell therapies.
Unilife upping device production as market opportunity offsets flat sales
Unilife Corporation has ramped up production of delivery devices as pharmas looks to differentiate injectable therapies from the competition.
update: WHO says tech like Nanopatch can help get vaccines to the people that need them
Vaxxas raises $20m for nanopatch vaccine trials
Vaccine patch firm Vaxxas has raised $20m (€17.7m) to fund clinical development of its pipeline of influenza, polio and bacterial infection vaccines.
Dispatches from BIO CEO 2015
Experts say industry interactions with US FDA improving
Though it’s difficult to quantify, industry experts told investors at the BIO CEO conference in New York on Monday that the US FDA-industry interactions are improving though there’s still some inconsistency between FDA leadership, division directors and...
Novo Nordisk to launch IT wing as separate company
Danish diabetes specialist Novo Nordisk plans to float its IT services business NNIT on the NASDAQ exchanged in Copenhagan.
EMA defends Humira redactions, says only commercial info was blacked out
The EMA has defended its decision to redact three Humira clinical study reports, arguing that the information held back was ‘commercially confidential.’
Merck's loss of HCV Breakthrough status shows FDA's pragmatism, says analyst
Stripping Merck & Co.'s hep C pill of breakthrough status shows the US FDA is monitoring market developments in real-time warns one industry analyst.